Meng Fang

Jingwei Shi, Zeyu Zhang, Biao Wu et al.

We present PresentAgent, a multimodal agent that transforms long-form documents into narrated presentation videos. While existing approaches are limited to generating static slides or text summaries, our method advances beyond these limitations by producing fully synchronized visual and spoken content that closely mimics human-style presentations. To achieve this integration, PresentAgent employs a modular pipeline that systematically segments the input document, plans and renders slide-style visual frames, generates contextual spoken narration with large language models and Text-to-Speech models, and seamlessly composes the final video with precise audio-visual alignment. Given the complexity of evaluating such multimodal outputs, we introduce PresentEval, a unified assessment framework powered by Vision-Language Models that comprehensively scores videos across three critical dimensions: content fidelity, visual clarity, and audience comprehension through prompt-based evaluation. Our experimental validation on a curated dataset of 30 document-presentation pairs demonstrates that PresentAgent approaches human-level quality across all evaluation metrics. These results highlight the significant potential of controllable multimodal agents in transforming static textual materials into dynamic, effective, and accessible presentation formats. Code will be available at https://github.com/AIGeeksGroup/PresentAgent.

Yipin Lei, Xu Wang, Meng Fang et al.

Peptides offer great biomedical potential and serve as promising drug candidates. Currently, the majority of approved peptide drugs are directly derived from well-explored natural human peptides. It is quite necessary to utilize advanced deep learning techniques to identify novel peptide drugs in the vast, unexplored biochemical space. Despite various in silico methods having been developed to accelerate peptide early drug discovery, existing models face challenges of overfitting and lacking generalizability due to the limited size, imbalanced distribution and inconsistent quality of experimental data. In this study, we propose PepGB, a deep learning framework to facilitate peptide early drug discovery by predicting peptide-protein interactions (PepPIs). Employing graph neural networks, PepGB incorporates a fine-grained perturbation module and a dual-view objective with contrastive learning-based peptide pre-trained representation to predict PepPIs. Through rigorous evaluations, we demonstrated that PepGB greatly outperforms baselines and can accurately identify PepPIs for novel targets and peptide hits, thereby contributing to the target identification and hit discovery processes. Next, we derive an extended version, diPepGB, to tackle the bottleneck of modeling highly imbalanced data prevalent in lead generation and optimization processes. Utilizing directed edges to represent relative binding strength between two peptide nodes, diPepGB achieves superior performance in real-world assays. In summary, our proposed frameworks can serve as potent tools to facilitate peptide early drug discovery.